000 01579 a2200445 4500
005 20250517024048.0
264 0 _c20151209
008 201512s 0 0 eng d
022 _a1539-2864
024 7 _a10.1097/IAE.0000000000000491
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSudhalkar, Aditya
245 0 0 _aANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION: A Comparative Study.
_h[electronic resource]
260 _bRetina (Philadelphia, Pa.)
_cJul 2015
300 _a1368-74 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aBevacizumab
_xtherapeutic use
650 0 4 _aChoroidal Neovascularization
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aFluorescein Angiography
650 0 4 _aHumans
650 0 4 _aIntravitreal Injections
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRanibizumab
_xtherapeutic use
650 0 4 _aRetina
_xpathology
650 0 4 _aRetrospective Studies
650 0 4 _aSubretinal Fluid
650 0 4 _aTomography, Optical Coherence
650 0 4 _aVascular Endothelial Growth Factor A
_xantagonists & inhibitors
650 0 4 _aVisual Acuity
_xphysiology
650 0 4 _aYoung Adult
700 1 _aYogi, Rohit
700 1 _aChhablani, Jay
773 0 _tRetina (Philadelphia, Pa.)
_gvol. 35
_gno. 7
_gp. 1368-74
856 4 0 _uhttps://doi.org/10.1097/IAE.0000000000000491
_zAvailable from publisher's website
999 _c24763211
_d24763211